KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

(RS)-baclofen, naltrexone hydrochloride and D-sorbitol
(D05113)

[3] Baclofen,
Naltrexone,
Sorbitol

[3] Sorbitol solution ,
Baclofen ,
Naltrexone (D05113) 💬

Name	Other Names
Sorbitol solution	Sorbitol solution (USP) D-Sorbitol (JP18) Sorbitol (NF) Sorbitol 3% in plastic container (TN)
Baclofen	Baclofen (JP18/USP/INN) Kemstro (TN) Lioresal (TN) FLEQSUVY GABLOFEN LYVISPAH OZOBAX
Naltrexone	Naltrexone (USAN/INN) Vivitrol (TN)

[5] GABBR1,
GABBR2,
OPRD1,
OPRK1,
OPRM1 💬

Name	Full Name
GABBR1	gamma-aminobutyric acid type B receptor subunit 1
GABBR2	gamma-aminobutyric acid type B receptor subunit 2
OPRD1	opioid receptor delta 1
OPRK1	opioid receptor kappa 1
OPRM1	opioid receptor mu 1

[9] Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, Taste transduction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬

[1] 10 💬

4.5 mg Naltrexone
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[1] 13 💬

Low dose naltrexone
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[2] 96, 97 💬

Low-dose naltrexone
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[1] 226 💬

NALTREXONE
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[12] 6, 10, 13, 40, 41, 42, 43, 44, 45, 96, 97, 226 💬

Disease ID	Name
6	Parkinson disease
10	Charcot-Marie-Tooth disease
13	Multiple sclerosis/Neuromyelitis optica
40	Takayasu arteritis
41	Giant cell arteritis
42	Polyarteritis nodosa
43	Microscopic polyangiitis
44	Wegener granulomatosis
45	Eosinophilic granulomatosis with Polyangiitis
96	Crohn disease
97	Ulcerative colitis
226	Interstitial cystitis with Hunners ulcer

NALTREXONE CLORIDRATO
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[1] 10 💬

NALTREXONE HYDROCHLORIDE
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[8] 10, 40, 41, 42, 43, 44, 45, 96 💬

Disease ID	Name
10	Charcot-Marie-Tooth disease
40	Takayasu arteritis
41	Giant cell arteritis
42	Polyarteritis nodosa
43	Microscopic polyangiitis
44	Wegener granulomatosis
45	Eosinophilic granulomatosis with Polyangiitis
96	Crohn disease

Naltrexone-HCl
(D05113)

[1] Naltrexone

[1] Naltrexone (D05113) 💬

[3] OPRD1,
OPRK1,
OPRM1 💬

[5] Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬

[1] 96 💬